Experimental studies in noncerebral cells (MCF-7 breast cancer cells, which contain abnormal gene expression profiles and exhibit a deregulated cell cycle control) have demonstrated that estrogen receptor (ER) binding to estrogen response elements (EREs) in gene promotors, drives microRNA expression thereby regulating multiple downstream target genes [40]. The gene discussed is ESR1; the disease is breast carcinoma.